×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

BtoB

IBM, AstraZeneca in $1.7B IT deal

Published on .

Armonk, N.Y.--In a $1.7 billion deal, IBM Corp. will begin to manage nearly all of London-based AstraZeneca plc's IT systems. IBM will oversee AstraZeneca's PC management services at all of its offices around the globe. As part of the deal, some 1,200 AstraZeneca employees will move to IBM. The deal is a boon for AstraZeneca, which will be able to concentrate on its core business of developing and marketing its high-profile drug brands, which include Xylocaine, Nolvadex and Pulmicort.
Most Popular
In this article: